Extremely saddened and disappointing to see long term shareholder started selling now.
Share price is 4 years low today, doesn’t look like it’s going to stop soon.
I understand it’s a bear market and sector is struggling but in my opinion, Company has failed to provide proper market updates (or strategy) on future direction on R&D projects, reimbursement in US, new clinical trials work and delivering on significant returns in revenue.
Note: I am not here to to down ramp the Company or target Directors/ Management or any other agenda.
All in my opinion and research.
RHT Price at posting:
5.2¢ Sentiment: None Disclosure: Not Held
